Profil
William D.
DeVaul is currently the Secretary & General Counsel at Morphic Therapeutic, Inc. and Morphic Holding, Inc. He previously worked as the Vice President-Intellectual Property at Evelo Biosciences, Inc. from 2015 to 2019 and as an Attorney at Cubist Pharmaceuticals LLC from 2003 to 2015.
He obtained his undergraduate degree from The Trustees of Columbia University in The City of New York and his graduate degree from Boston University School of Law.
Postes actifs de William DeVaul
| Sociétés | Poste | Début |
|---|---|---|
| MORC HOLD | Conseiller Juridique Général | 01/02/2019 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Conseiller Juridique Général | - |
Anciens postes connus de William DeVaul
| Sociétés | Poste | Fin |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | 01/02/2019 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/02/2015 |
Formation de William DeVaul
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evelo Biosciences, Inc.
Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
















